SCHEMBL6346755

SCHEMBL6346755

CCc1ncc(-c2ccccc2C)nc1CC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HEXA P06865 1/20 0.46
HEXB P07686 1/20 0.46
PDCD1 Q15116 5/20 0.44
CD274 Q9NZQ7 5/20 0.44
IDO1 P14902 1/20 0.42
METAP2 P50579 1/20 0.42
PRKDC P78527 1/20 0.41
ATR Q13535 1/20 0.41
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
ALOX12 P18054 1/20 0.39
MAPK10 P53779 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
CYP1A2 P05177 5/20 0.38
CYP2D6 P10635 5/20 0.38
CYP2C19 P33261 5/20 0.38
CLK4 Q9HAZ1 3/20 0.38
CYP3A4 P08684 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10305022 0.85 HEXA (0.54) HEXAHEXBPDCD1CD274IDO1
SCHEMBL26328027 0.84 PDCD1 (0.40) HEXAHEXBPDCD1CD274PRKDC
SCHEMBL6349429 0.80 PDCD1 (0.45) PDCD1CD274ATRALDH1A1TLR8
SCHEMBL6356399 0.77 NPC1 (0.47) HEXAHEXBALDH1A1MAPTMEN1
SCHEMBL3424160 0.75 IDO1 (0.55) IDO1METAP2PRKDCATRALDH1A1
SCHEMBL6410531 0.74 IDO1 (0.47) IDO1METAP2PRKDCATRALDH1A1
SCHEMBL9453979 0.73 ALDH1A1 (0.66) IDO1METAP2PRKDCATRALDH1A1
SCHEMBL28174453 0.71 ATR (0.56) HEXAHEXBIDO1METAP2PRKDC
Hydrochloric Acid SCHEMBL28048607 0.71 ALDH1A1 (0.64) IDO1METAP2PRKDCATRALDH1A1
SCHEMBL16801759 0.70 NPC1 (0.44) PDCD1CD274IDO1METAP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050176721-A1 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines HUANG JIANHUA (US) 2005-08-11 US disclosed
US-6887875-B2 Bind with high selectivity and/ or high affinity to CRF1 receptors (Corticotropin Releasing Factor 1 Receptors), useful for treating psychiatric and neurological diseases, including depression, anxiety and post trauma stress NEUROGEN CORPORATION (US) 2005-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176721-A1 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines CRHR2, CRHR1, CRH HEXA 3069/4885HEXB 3054/4885PDCD1 1227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.